Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 140
10
Diseases
15
Unique genes
0.252
Avg. similarity score
Cardiac rhythm disease
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cardiac rhythm disease
SCN5A-related cardiac rhythm disorder
dilated cardiomyopathy 1E
Atrial standstill
Ectopic rhythm
Paroxysmal tachycardia
Paroxysmal ventricular fibrillation
Torsades de pointes
Hypercapnia
primary ciliary dyskinesia 5
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cardiac rhythm disease | 7 | 7 | 2 |
| SCN5A-related cardiac rhythm disorder | 7 | 7 | 1 |
| dilated cardiomyopathy 1E | 7 | 7 | 1 |
| Atrial standstill | 5 | 5 | 3 |
| Ectopic rhythm | 5 | 5 | 2 |
| Paroxysmal tachycardia | 4 | 4 | 7 |
| Paroxysmal ventricular fibrillation | 4 | 4 | 2 |
| Torsades de pointes | 3 | 3 | 3 |
| Hypercapnia | 1 | 1 | 2 |
| primary ciliary dyskinesia 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SCN5A | 8 / 10 | Atrial standstill, Cardiac rhythm disease, dilated cardiomyopathy 1E, Ectopic rhythm and 4 more |
| HYDIN | 2 / 10 | Paroxysmal tachycardia, primary ciliary dyskinesia 5 |
| NPPA | 2 / 10 | Atrial standstill, Hypercapnia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Voltage gated Potassium channels | Reactome | 2 / 43 | 37.2× | 1.28e-3 | 1.63e-2 ✓ sig. |
| Opioid Signalling | Reactome | 1 / 3 | 267× | 3.74e-3 | 3.59e-2 ✓ sig. |
| CREB3 factors activate genes | Reactome | 1 / 5 | 160× | 6.23e-3 | 5.06e-2 |
| NOSTRIN mediated eNOS trafficking | Reactome | 1 / 5 | 160× | 6.23e-3 | 5.06e-2 |
| Biosynthesis of maresin-like SPMs | Reactome | 1 / 6 | 133× | 7.47e-3 | 5.69e-2 |
| Phase 1 - inactivation of fast Na+ channels | Reactome | 1 / 7 | 114× | 8.71e-3 | 6.31e-2 |
| Phase 3 - rapid repolarisation | Reactome | 1 / 8 | 100× | 9.95e-3 | 6.82e-2 |
| Spinocerebellar ataxia | KEGG | 2 / 144 | 11.1× | 1.35e-2 | 8.18e-2 |
| FOXO-mediated transcription of cell cycle genes | Reactome | 1 / 11 | 72.8× | 1.37e-2 | 8.23e-2 |
| Physiological factors | Reactome | 1 / 12 | 66.7× | 1.49e-2 | 8.66e-2 |
| Phagosome | KEGG | 2 / 155 | 10.3× | 1.56e-2 | 8.90e-2 |
| eNOS activation | Reactome | 1 / 13 | 61.6× | 1.61e-2 | 9.11e-2 |
| Trafficking and processing of endosomal TLR | Reactome | 1 / 13 | 61.6× | 1.61e-2 | 9.11e-2 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 1 / 14 | 57.2× | 1.74e-2 | 9.50e-2 |
| Tuberculosis | KEGG | 2 / 181 | 8.8× | 2.09e-2 | 1.05e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| regulation of heart rate by cardiac conduction | GO:0086091 | 5 / 43 | 145× | 1.50e-10 | 4.13e-8 ✓ sig. |
| cardiac conduction system development | GO:0003161 | 3 / 16 | 234× | 2.33e-7 | 2.46e-5 ✓ sig. |
| ventricular cardiac muscle cell action potential | GO:0086005 | 3 / 17 | 220× | 2.83e-7 | 2.90e-5 ✓ sig. |
| regulation of ventricular cardiac muscle cell membrane repolarization | GO:0060307 | 3 / 21 | 178× | 5.52e-7 | 5.08e-5 ✓ sig. |
| AV node cell to bundle of His cell communication | GO:0086067 | 2 / 3 | 831× | 1.80e-6 | 1.33e-4 ✓ sig. |
| regulation of atrial cardiac muscle cell membrane repolarization | GO:0060372 | 2 / 6 | 415× | 9.00e-6 | 4.81e-4 ✓ sig. |
| SA node cell action potential | GO:0086015 | 2 / 6 | 415× | 9.00e-6 | 4.81e-4 ✓ sig. |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 / 7 | 356× | 1.26e-5 | 6.25e-4 ✓ sig. |
| regulation of atrial cardiac muscle cell membrane depolarization | GO:0060371 | 2 / 10 | 249× | 2.70e-5 | 1.13e-3 ✓ sig. |
| membrane repolarization during cardiac muscle cell action potential | GO:0086013 | 2 / 10 | 249× | 2.70e-5 | 1.13e-3 ✓ sig. |
| membrane depolarization during action potential | GO:0086010 | 2 / 10 | 249× | 2.70e-5 | 1.13e-3 ✓ sig. |
| negative regulation of potassium ion transmembrane transport | GO:1901380 | 2 / 13 | 192× | 4.67e-5 | 1.71e-3 ✓ sig. |
| membrane repolarization during ventricular cardiac muscle cell action potential | GO:0098915 | 2 / 13 | 192× | 4.67e-5 | 1.71e-3 ✓ sig. |
| membrane repolarization | GO:0086009 | 2 / 14 | 178× | 5.44e-5 | 1.92e-3 ✓ sig. |
| potassium ion export across plasma membrane | GO:0097623 | 2 / 15 | 166× | 6.28e-5 | 2.13e-3 ✓ sig. |